ITCI Intra-Cellular Therapies
- 70.260
- +1.460+2.12%
Intra-Cellular Therapies所有资讯
Intra-Cellular Therapies | 4：持股变动声明-高管 Mates Sharon
Intra-Cellular Therapies | 4：持股变动声明-董事 VAN NOSTRAND ROBERT L
Intra-Cellular Therapies | 4：持股变动声明-董事 RIGGS RORY B
Intra-Cellular Therapies | 4：持股变动声明-董事 RIGGS RORY B
Intra-Cellular Therapies | 4：持股变动声明-高管 Mates Sharon
Intra-Cellular Therapies | 4：持股变动声明-高管 Hineline Lawrence J.
Intra-Cellular Therapies | 4：持股变动声明-高管 Halstead Michael
Intra-Cellular Therapies | 4：持股变动声明-高管 Neumann Mark
Intra-Cellular Therapies | 4：持股变动声明-高管 Durgam Suresh K.
Intra-Cellular Therapies | 4：持股变动声明-高管 Neumann Mark
Intra-Cellular Therapies | 4：持股变动声明-高管 Mates Sharon
Intra-Cellular Therapies | 4：持股变动声明-高管 Halstead Michael
Intra-Cellular Therapies | 4：持股变动声明-高管 Hineline Lawrence J.
Intra-Cellular Therapies | 4：持股变动声明-高管 Durgam Suresh K.
Intra-Cellular Therapies | 4：持股变动声明-高管 Hineline Lawrence J.
Intra-Cellular Therapies | 4：持股变动声明-高管 Halstead Michael
Intra-Cellular Therapies | 4：持股变动声明-高管 Neumann Mark
Intra-Cellular Therapies | 4：持股变动声明-高管 Durgam Suresh K.
Intra-Cellular Therapies | 4：持股变动声明-高管 Mates Sharon
Intra-Cellular Therapies | 4：持股变动声明-董事 VAN NOSTRAND ROBERT L
分析
目标价预测
暂无数据
